title: Decreased Expression of DREAM Promotes the Degeneration of Retinal Neurons.
abstract: The intrinsic mechanisms that promote the degeneration of retinal ganglion cells (RGCs) following the activation of N-Methyl-D-aspartic acid-type glutamate receptors (NMDARs) are unclear. In this study, we have investigated the role of downstream regulatory element antagonist modulator (DREAM) in NMDA-mediated degeneration of the retina. NMDA, phosphate-buffered saline (PBS), and MK801 were injected into the vitreous humor of C57BL/6 mice. At 12, 24, and 48 hours after injection, expression of DREAM in the retina was determined by immunohistochemistry, western blot analysis, and electrophoretic mobility-shift assay (EMSA). Apoptotic death of cells in the retina was determined by terminal deoxynucleotidyl transferace dUTP nick end labeling (TUNEL) assays. Degeneration of RGCs in cross sections and in whole mount retinas was determined by using antibodies against Tuj1 and Brn3a respectively. Degeneration of amacrine cells and bipolar cells was determined by using antibodies against calretinin and protein kinase C (PKC)-alpha respectively. DREAM was expressed constitutively in RGCs, amacrine cells, bipolar cells, as well as in the inner plexiform layer (IPL). NMDA promoted a progressive decrease in DREAM levels in all three cell types over time, and at 48 h after NMDA-treatment very low DREAM levels were evident in the IPL only. DREAM expression in retinal nuclear proteins was decreased progressively after NMDA-treatment, and correlated with its decreased binding to the c-fos-DRE oligonucleotides. A decrease in DREAM expression correlated significantly with apoptotic death of RGCs, amacrine cells and bipolar cells. Treatment of eyes with NMDA antagonist MK801, restored DREAM expression to almost normal levels in the retina, and significantly decreased NMDA-mediated apoptotic death of RGCs, amacrine cells, and bipolar cells. Results presented in this study show for the first time that down-regulation of DREAM promotes the degeneration of RGCs, amacrine cells, and bipolar cells.
authors.affiliation: Laboratory of Ophthalmic Neurobiology, and Eye Research Institute of Oakland University, Rochester, Michigan, United States of America.
authors.forename: Shravan
authors.initials: S
authors.lastname: Chintala
authors.affiliation: Laboratory of Ophthalmic Neurobiology, and Eye Research Institute of Oakland University, Rochester, Michigan, United States of America.
authors.forename: Mei
authors.initials: M
authors.lastname: Cheng
authors.affiliation: Laboratory of Ophthalmic Neurobiology, and Eye Research Institute of Oakland University, Rochester, Michigan, United States of America.
authors.forename: Xiao
authors.initials: X
authors.lastname: Zhang
mesh_terms: D025042:Amacrine Cells / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D017209:Apoptosis; D005136:Eye Proteins / Q000096:biosynthesis*; D005786:Gene Expression Regulation; D051605:Kv Channel-Interacting Proteins / Q000096:biosynthesis*; D051379:Mice; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism; D012097:Repressor Proteins / Q000096:biosynthesis*; D051245:Retinal Bipolar Cells / Q000378:metabolism* / Q000473:pathology; D012165:Retinal Ganglion Cells / Q000378:metabolism* / Q000473:pathology
chemical_list: C496756:Csen protein, mouse; D005136:Eye Proteins; D051605:Kv Channel-Interacting Proteins; D016194:Receptors, N-Methyl-D-Aspartate; D012097:Repressor Proteins